Replies to post #78228 on $heff's $tation of $tocks & $olid DD

[42Delta]

EXEL Up 7% pre-market on Cometriq approval in Europe. Although down overall the past few weeks this one has held up well recently against the overall biotech selling.

[$heff]

$EXEL.. Exelixis Receives Approval for COMETRIQ® (Cabozantinib) in the European Unio.. http://t.co/CNuD6bXG1D